Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • On the Market
  • Published:

Nanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicity

Abstract

Cisplatin is one of the most widely used agents in the treatment of solid tumors, but its clinical utility is limited by toxicity. The development of less toxic, liposomal formulations of cisplatin has been hampered by the low water solubility and low lipophilicity of cisplatin, resulting in very low encapsulation efficiencies. We describe a novel method allowing the efficient encapsulation of cisplatin in a lipid formulation; it is based on repeated freezing and thawing of a concentrated solution of cisplatin in the presence of negatively charged phospholipids. The method is unique in that it generates nanocapsules, which are small aggregates of cisplatin covered by a single lipid bilayer. The nanocapsules have an unprecedented drug-to-lipid ratio and an in vitro cytotoxicity up to 1000-fold higher than the free drug. Analysis of the mechanism of nanocapsule formation suggests that the method may be generalized to other drugs showing low water solubility and lipophilicity.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Cytotoxicity towards human ovarian carcinoma cells.
Figure 2: Nanocapsules of cisplatin: isolation and characterization.
Figure 3: Cytotoxicity and sizing of nanocapsules of cisplatin.
Figure 4: Mechanism of nanocapsule formation and cell interaction.

References

  1. Lippert, B. (ed.) Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug (Wiley-VCH, New York, 1999).

    Book  Google Scholar 

  2. Burger, K.N.J., Staffhorst, R.W.H.M. & de Kruijff, B. Interaction of the anti-cancer drug cisplatin with phosphatidylserine in intact and semi-intact cells. Biochim. Biophys. Acta 1419, 43–54 (1999).

    Article  CAS  Google Scholar 

  3. Reedijk, J. Why does cisplatin reach Guanine-N7 with competing S-donor ligands available in the cell? Chem. Rev. 99, 2499–2510 (1999).

    Article  CAS  Google Scholar 

  4. Howe-Grant, M.E. & Lippard, S.J. Aqueous platinum(II) chemistry; binding to biological molecules. in Metal Ions in Biological Systems Vol. XI (ed. Sigel, H.) 63–125 (M. Dekker, New York, 1980).

    Google Scholar 

  5. Long, D.F. & Repta, A.J. Cisplatin: chemistry, distribution and biotransformation. Biopharm. Drug Dispos. 2, 1–16 (1981).

    Article  CAS  Google Scholar 

  6. Sharma, A. & Sharma, U.S. Liposomes in drug delivery: progress and limitations. Int. J. Pharm. 154, 123–140 (1997).

    Article  CAS  Google Scholar 

  7. Newman, M.S., Colbern, G.T., Working, P.K., Engbers, C. & Amantea, M.A. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice. Cancer Chemother. Pharmacol. 43, 1–7 (1999).

    Article  CAS  Google Scholar 

  8. Sur, B., Ray, R.R., Sur, P. & Roy, D.K. Effect of liposomal encapsulation of cis-platinum diamminodichloride in the treatment of Ehrlich ascites carcinoma. Oncology 40, 372–376 (1983).

    Article  CAS  Google Scholar 

  9. Steerenberg, P.A., et al. Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution. Cancer Chemother. Pharmacol. 21, 299–307 (1988).

    Article  CAS  Google Scholar 

  10. Perez-Soler, R. et al. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions. Clin. Cancer Res. 3, 373–379 (1997).

    CAS  PubMed  Google Scholar 

  11. Hope, M.J., Bally, M.B., Mayer, L.D., Janoff, A.S. & Cullis, P.R. Generation of multilamellar and unilamellar phospholipid vesicles. Chem. Phys. Lipids 40, 89–107 (1986).

    Article  Google Scholar 

  12. Riley, C.M. & Sternson, L.A. Cisplatin. In Analytical Profiles of Drug Substances, Vol. 14, (ed. Florey, K.) 78–105 (Academic, New York, 1985).

    Google Scholar 

  13. Lewis, B.A. & Engelman, D.M. Lipid bilayer thickness varies linearly with acyl chain length in fluid phosphatidylcholine vesicles. J. Mol. Biol. 166, 211–217 (1983).

    Article  CAS  Google Scholar 

  14. Burnell, E.E., Cullis, P.R. & de Kruijff, B. Effects of tumbling and lateral diffusion on phosphatidylcholine model membrane 31P-NMR lineshapes. Biochim. Biophys. Acta 603, 63–69 (1980).

    Article  CAS  Google Scholar 

  15. Appleton, T.G., Berry, R.D., Davis, C.A., Hall, J.R. & Kimlin, H.A. Reactions of platinum(II) aqua complexes. 1. Multinuclear (195Pt, 15N, and 31P) NMR study of reactions between the cis-diamminediaquaplatinum(II) cation and the oxygen-donor ligands hydroxide, perchlorate, nitrate, sulfate, phosphate, and acetate. Inorg. Chem. 23, 3514–3521 (1984).

  16. Chapman, C.J., Erdahl, W.E., Taylor, R.W. & Pfeiffer, D.R. Effects of solute concentration on the entrapment of solutes in phospholipid vesicles prepared by freeze-thaw extrusion. Chem. Phys. Lipids 60, 201–208 (1991).

    Article  CAS  Google Scholar 

  17. Speelmans, G., Staffhorst, R.W.H.M., Versluis, K., Reedijk, J. & de Kruijff, B. Cisplatin complexes with phosphatidylserine in membranes. Biochemistry 36, 10545–10550 (1997).

    Article  CAS  Google Scholar 

  18. Bandak, S., Goren, D., Horowitz, A., Tzemach, D. & Gabizon, A. Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models. Anticancer Drugs 10, 911–920 (1999).

    Article  CAS  Google Scholar 

  19. Skehan, P. et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82, 1107–1112 (1990).

    Article  CAS  Google Scholar 

  20. Frederik, P.M., Stuart, M.C., Bomans, P.H. & Busing, W.M. Phospholipid, nature's own slide and cover slip for cryo- electron microscopy. J. Microsc. 153, 81–92 (1989).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank N. Jelluma, V. Chupin and W. Mulder for experimental support, J. Reedijk and T. de Kroon for helpful discussions, and the Dutch Cancer Society (N.K.B.) for financial support (project UU2001-2493).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Koert N.J. Burger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Burger, K., Staffhorst, R., de Vijlder, H. et al. Nanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicity. Nat Med 8, 81–84 (2002). https://doi.org/10.1038/nm0102-81

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0102-81

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing